Taigen Biopharmaceutica (Taiwan) Analysis
4157 Stock | TWD 11.45 0.35 2.97% |
Taigen Biopharmaceuticals Holdings is overvalued with Real Value of 10.38 and Hype Value of 11.45. The main objective of Taigen Biopharmaceutica stock analysis is to determine its intrinsic value, which is an estimate of what Taigen Biopharmaceuticals Holdings is worth, separate from its market price. There are two main types of Taigen Biopharmaceutica's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Taigen Biopharmaceutica's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Taigen Biopharmaceutica's stock to identify patterns and trends that may indicate its future price movements.
The Taigen Biopharmaceutica stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Taigen Biopharmaceutica is usually not traded on No Trading . Market opens only for Clearing & Settlement 2, Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2, Mid - autumn / Moon Festival. Taigen Stock trading window is adjusted to Asia/Taipei timezone.
Taigen |
Taigen Stock Analysis Notes
About 36.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. For more info on Taigen Biopharmaceuticals Holdings please contact KuoLung Huang at 886 2 8177 7020 or go to https://www.taigenbiotech.com.tw.Taigen Biopharmaceutica Investment Alerts
Taigen Biopharmaceutica generated a negative expected return over the last 90 days | |
Taigen Biopharmaceutica has high likelihood to experience some financial distress in the next 2 years | |
About 36.0% of the company shares are owned by insiders or employees |
Taigen Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 11.33 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taigen Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Taigen Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 15th of December 2024, Taigen Biopharmaceutica has the Coefficient Of Variation of (484.32), risk adjusted performance of (0.14), and Variance of 2.31. Taigen Biopharmaceutica technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Taigen Biopharmaceutica mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Taigen Biopharmaceutica is priced more or less accurately, providing market reflects its prevalent price of 11.45 per share.Taigen Biopharmaceutica Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Taigen Biopharmaceutica middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Taigen Biopharmaceutica. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Taigen Biopharmaceutica Outstanding Bonds
Taigen Biopharmaceutica issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Taigen Biopharmaceutica uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Taigen bonds can be classified according to their maturity, which is the date when Taigen Biopharmaceuticals Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Taigen Biopharmaceutica Predictive Daily Indicators
Taigen Biopharmaceutica intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Taigen Biopharmaceutica stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Taigen Biopharmaceutica Forecast Models
Taigen Biopharmaceutica's time-series forecasting models are one of many Taigen Biopharmaceutica's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Taigen Biopharmaceutica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Taigen Biopharmaceutica to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
All Next | Launch Module |
Additional Tools for Taigen Stock Analysis
When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.